VANCOUVER, BC / ACCESSWIRE / August 2, 2022 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FRA:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in ...

What if CAR T cells, revolutionary cancer fighters normally manufactured in the lab, could be created inside the patient? This quest to simplify CAR T therapy has brought two biotech companies to a ...

Injecting regulatory T cells or Tregs, which control the body’s immune responses, directly into damaged bone, muscle and skin significantly boosts healing, according to new research. The door is now ...

A single injection of a new, off-the-shelf stem cell therapy for knee osteoarthritis significantly improved pain and function for up to 12 months in 75% of participants involved in a clinical trial.

Doctors have been raising questions about a video on social media of a physician allegedly injecting stem cells into the carotid artery of a fully awake patient. A physician wearing blue nitrile ...

CHICAGO -- Intracerebroventricular (ICV) delivery of bivalent CAR T-cells targeting EGFR and IL13Rα2 was feasible and appeared safe in patients with recurrent glioblastoma (GBM) in a phase I study ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Pralatrexate Injection, a generic equivalent to Folotyn ®, for the treatment of relapsed or refractory peripheral T ...

Please provide your email address to receive an email when new articles are posted on . Cell-based injections were not superior to corticosteroid injection for patients with knee OA. Pain scores and ...